Insider trades
Frederick G. Vogt, CEO of Iovance Biotherapeutics IOVA, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/05.
Frederick G. Vogt
Interim CEO & General Counsel
- Company
- Iovance Biotherapeutics IOVA
- First filing
- 23/01/19
- Trades
- 80 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/05/14 | 25/05/16 | 25,000 sh | $1.69 | $42,250 | +7.2% |